Articles by Daniel Marsh
Cloud ETFs Rally on Cooling Inflation, Palo Alto Earnings Loom
Major cloud computing ETFs surged Friday after a cooler-than-expected inflation report lifted rate-sensitive tech stocks. Attention now turns to Palo Alto Networks' quarterly results due after Tuesday's close.
Dow Closes Near 49,500 as Softer CPI Eases Rate Fears
The Dow Jones Industrial Average closed at 49,500.93 Friday, lifted by a cooler-than-expected inflation report. The blue-chip index still fell 1.2% for the week.
Caterpillar Shares Hold Near Highs as Insider Sale Filing Emerges
Caterpillar shares closed up 2.1% at $774.20, staying near highs following an insider sale filing. Attention shifts to CFO Andrew Bonfield's scheduled public remarks.
Amazon Enters Bear Market Amid AI Spending Concerns, Italy Probe
Amazon shares have entered a technical bear market, dropping 18% over nine consecutive sessions. The decline reflects investor anxiety over the company's planned $200 billion AI infrastructure investment and a new tax probe in Italy.
Tesla Holds Near $417 Amid Holiday Pause, Inflation Data in View
Tesla shares closed nearly flat at $417.44 ahead of a market holiday. Rivian jumped 25% on a strong delivery outlook, refocusing attention on affordable EVs.
Datavault AI Warrant Dividend Date Shift Sparks 8.6% Stock Surge
Datavault AI shares surged 8.6% following the company's decision to postpone its warrant dividend distribution to February 23. The move triggered heavy trading volume approaching 97 million shares.
Nike Shares Gain on Converse Restructuring and Dividend Announcement
Nike shares advanced 3.2% following news of a Converse corporate restructuring and a declared $0.41 quarterly dividend. The stock gave back a slight margin after hours.
Danaher Shares Slip Ahead of Holiday, Traders Eye PCE Data
Danaher shares fell in extended trading Friday, closing near $212.58. The dip precedes a market holiday, with attention shifting to next week's key inflation report.
Merck Shares Gain on Deutsche Bank Upgrade Ahead of Key Cancer Data
Merck shares advanced following a Deutsche Bank upgrade to Buy and a raised price target, with investors focused on upcoming oncology data at the ASCO GU symposium.


